Odyssean »

Southern Company shares owned by Odyssean

Quarter-by-quarter ownership of Southern Company (SO) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Southern Company

Tip: Access up to 7 years of quarterly data

All positions including Southern Company held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Southern Company by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.0M 32k 95.71

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Southern Company

BlackRock
Vanguard Capital Management
State Street Corporation
Capital World Investors
T. Rowe Price Associates
Jpmorgan Chase & Co
Geode Capital Management
Vanguard Portfolio Management
FMR
Franklin Resources
Massachusetts Financial Services
Goldman Sachs Group
Morgan Stanley
Northern Trust
Ameriprise Financial

View all funds holding Southern Company